FairyGene, Inc., 2 Pearl Buck Court, Suite 1 Bristol , PA 19007 United StatesFEI 3023594691Issued Jul 31, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3023594691.
Violations5
Issue DateJul 31, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
FairyGene, Inc.
Location
FairyGene, Inc., 2 Pearl Buck Court, Suite 1 Bristol , PA 19007 United States
FEI Number
3023594691
Country
United States
Issue Date
July 31, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated
Talk to a Specialist